Colony Family Offices, LLC Curis Inc Transaction History

Colony Family Offices, LLC

  • $267 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 02, 2022
BUY
$4.45 - $8.09 $35,600 - $64,720
8,000 Added 39.24%
28,387 $135,000
Q3 2021

Oct 21, 2021
SELL
$6.94 - $8.85 $55,520 - $70,800
-8,000 Reduced 28.18%
20,387 $160,000
Q2 2021

Sep 01, 2021
BUY
$7.45 - $16.27 $211,483 - $461,856
28,387 New
28,387 $229,000

About CURIS INC

CRIS Quotes by TradingView
  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $393M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track Colony Family Offices, LLC Portfolio

Follow Colony Family Offices, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Colony Family Offices, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Colony Family Offices, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email